SYNOPSIS Laboratory studies with the trichomonacidal agent, metronidazole, show that 66 strains of T. vaginalis were killed in three days by concentrations of 0O0625 ug./ml. to 1 ,ug./ml.
SYNOPSIS Laboratory studies with the trichomonacidal agent, metronidazole, show that 66 strains of T. vaginalis were killed in three days by concentrations of 0O0625 ug./ml. to 1 ,ug./ml.
Estimations of serum and urine levels in nine volunteers, the serum levels in 31 women, and the urine levels in 33 women show that metronidazole is rapidly absorbed and excreted in high concentration in the urine.
Development of resistance to metronidazole by T. vaginalis has not been demonstrated either in vivo or in vitro.
No toxic effect was demonstrated in the blood, liver, or kidney.
For some time it has been apparent that the effective treatment of infections due to T. vaginalis lies in a systematically administered drug. Aminitrazole was introduced in America (Plentl, Gray, Neslen, and Dalali, 1956 ) but whereas in common with many other compounds it showed considerable activity in vitro, it failed to produce blood levels and its use has been discontinued following unsuccessful trials (Catterall and Nicol, 1957; Dunlop, Philipp, and Watt, 1958; Jennison, 1957; Willcox, 1957) . In France, Cosar and Julou (1959) investigated metronidazole and found that it had a high antitrichomonal activity. Durel et al. (1960) showed that effective blood concentrations of this drug were obtained after oral administration and correlated this with cure of trichomoniasis and lack of toxicity. The efficacy of metronidazole has since been confirmed in Great Britain (Moffett and McGill, 1960; Rees, 1960; Watt and Jennison, 1960a) .
Metronidazole has the formula 1-beta-hydroxyethyl-2-methyl-5-nitroimidazole. Its solubility in water is approximately 1 %, and in ethanol, ether, and chloroform approximately 0 5 %. The pH of a saturated aqueous solution at 200C. is about 5-8. In the dosage used clinically it has no bactericidal activity and therefore does not interfere with normal vaginal flora. It has no antifungal activity.
The clinical trial of metronidazole reported by Watt and Jennison (1960a) continues, and the present paper describes some of the laboratory inReceived for publication 10 October 1960. vestigations carried out during that trial. These investigations were directed towards elucidating the following points: (1) The sensitivity in vitro of various strains of T. vaginalis to metronidazole; (2) the possible development of acquired resistance to the drug in vitro or in vivo; (3) the levels of metronidazole in the blood and urine after ingestion of single doses by volunteers and after treatment with the recommended total dosage; (4) the possibility of toxic effects of the drug on the blood, liver, and kidneys.
MATERIAL AND METHODS
One hundred and eight women suffering from vaginal trichomoniasis have been treated with metronidazole as out-patients. The methods of diagnosis and tests of cure were as described in a previous paper (Watt and Jennison, 1960a) Jennison, 1960b ).
The medium used for isolation of T. vaginalis was described by Stenton (1957) , except that if monilia were seen in direct examination nystatin was added to the medium for primary culture. The same medium, omitting antibiotics in case of possible synergistic action, was used in the estimation of blood and urine levels of metronidazole and the sensitivity of T. vaginalis to that drug.
The stock strain of T. vaginalis used throughout these investigations had been isolated about seven months previously. This stock strain was maintained by subculturing 0-1 ml. of culture into 10 ml. of fresh medium every three days. It was considered that by subculturing frequently and using a measured inoculum of T. vaginalis standardization could be maintained throughout the investigation. The sensitivity of the stock strain was determined at first biweekly and later at weekly intervals. After 40 subcultures no change in sensitivity was noted.
Trichomonacidal levels ofmetronidazole for the various strains of T. vaginalis were estimated by subculturing 0-1 ml. of a three-day growth of culture into 10 ml. of Stenton's medium containing serial dilutions of metronidazole and incubating for three days at 37°C. The cultures were then examined microscopically for living protozoa. Serum and urine levels were similarly determined by inoculating the stock strain of T. vaginalis in the ratio of 1:100 into medium containing dilutions of serum and urine. By comparison with the sensitivity of the stock strain the amount of metronidazole in serum or urine could be estimated.
RESULTS OF INVESTIGATIONS SENSITIVITY OF T. VAGINALIS TO METRONIDAZOLE
Sixty-six strains of T. vaginalis were tested for sensitivity to metronidazole; 55 Haemoglobin estimations, red cell, total and differential white cell, and platelet counts were carried out before and after treatment in eight patients and at various times up to three months after treatment in 48 patients. No significant change in the blood picture was noted.
Serum alkaline phosphatase and serum glutamic pyruvic transaminase were estimated in 12 patients after completion of the course of treatment but no increase in values occurred.
In most patients the urine was examined for albumin, cells, and casts but no abnormality was detected. DISCUSSION Durel, Roiron, Siboulet, and Borel (1960) , using the method described by Bushby and Copp (1955) , found that the inhibitory level of metronidazole was 1: 400,000 in vitro. This is based on the 99% death rate at 24 hours, and, using this method, we demonstrated inhibitory levels between 1: 300,000 and 1: 500,000 in six strains. But the method used throughout this investigation differs in that, since three days is required for maximum growth in the medium used, the concentration of the drug in which no growth had occurred at the end of three days' incubation was taken as the trichomonacidal level. This method also more closely simulates the conditions in a patient undergoing treatment, both as regards sensitivity of the strain of trichomonad and the blood levels. The longer incubation caused inhibition at concentrations which would have allowed growth after 24 hours and by this method trichomonacidal levels have been found to vary from 1 : 1,000,000 to 1 :13,300,000 (l,Ig./ml. to 0 075 ,ug./ml.).
The inverse relationship between time and drug concentration was also apparent in the experiments designed to induce resistance in vitro. This is the converse of the effect of nystatin on C. albicans where the yeasts grow in higher concentrations of the antibiotic following prolonged incubation (Jennison and Stenton, 1957 Approximately 20% of patients treated with metronidazole reported minor side-effects (Watt and Jennison, 1960a) , but examination of the cellular elements of the blood, liver function tests, and urine analysis revealed no abnormality. These investigations have not demonstrated any toxic effect due to metronidazole but final assessment must await more extensive use of the drug.
